Teva Pharmaceutical Industries Ltd TEVA
14 insiders sold $40.0M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $46.9M sold on 16 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Roberto Mignone Director |
- | $14.4M | Sep 18, 2026 |
| Richard D. Francis President and CEO |
- | $10.8M | Nov 10, 2026 |
| Mark Sabag See "Remarks" |
- | $3.9M | Nov 12, 2026 |
| Eliyahu Sharon Kalif EVP, Chief Financial Officer |
- | $3.6M | Jun 11, 2026 |
| Richard Daniell EVP, Europe Commercial |
- | $1.9M | Nov 11, 2026 |
| Amir Weiss Chief Accounting Officer |
- | $1.1M | Nov 9, 2026 |
| Dov Bergwerk Interim Cheif Legal Officer |
- | $1.1M | Nov 4, 2026 |
| Eric A. Hughes See "Remarks" |
- | $892K | Aug 3, 2026 |
| Matthew Shields EVP, Global Operations |
- | $854K | Jun 18, 2026 |
| Evan Lippman EVP, Business Development |
- | $680K | Aug 17, 2026 |
| Placid Jover See "Remarks" |
- | $447K | Aug 3, 2026 |
| Brian Savage Interim Chief Legal Officer |
- | $285K | Sep 18, 2026 |
| Ronit Satchi-Fainaro Director |
- | $15K | Aug 21, 2026 |
| Tal Zvi Zaks Director |
- | $593 | Aug 5, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 25 open-market sales by officers and directors, 0 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Mark Sabag | Sale | -44,710 | 2.0M |
| Nov 11, 2026 | Richard Daniell | Sale | -20,003 | 856K |
| Nov 10, 2026 | Richard D. Francis | Sale (10b5-1) | -250,000 | 10.6M |
| Nov 9, 2026 | Amir Weiss | Sale | -662 | 29K |
| Nov 9, 2026 | Amir Weiss | Sale | -7,093 | 305K |
| Nov 9, 2026 | Amir Weiss | Sale | -9,534 | 410K |
| Nov 9, 2026 | Richard Daniell | Sale | -25,000 | 1.1M |
| Nov 5, 2026 | Mark Sabag | Sale | -46,000 | 1.9M |
| Nov 4, 2026 | Dov Bergwerk | Sale | -17,505 | 730K |
| Nov 4, 2026 | Dov Bergwerk | Sale | -8,755 | 365K |
| Sep 18, 2026 | Roberto Mignone (indirect) | Sale | -367,600 | 14.4M |
| Sep 18, 2026 | Brian Savage | Sale | -4,503 | 174K |
| Sep 18, 2026 | Brian Savage | Sale | -2,525 | 99K |
| Sep 18, 2026 | Brian Savage | Sale | -314 | 12K |
| Aug 21, 2026 | Ronit Satchi-Fainaro | Sale | -415 | 15K |
| Aug 21, 2026 | Amir Weiss | Sale | -6,945 | 261K |
| Aug 21, 2026 | Amir Weiss | Sale | -2,500 | 94K |
| Aug 17, 2026 | Evan Lippman | Sale (10b5-1) | -18,600 | 680K |
| Aug 5, 2026 | Tal Zvi Zaks | Sale | -17 | 593 |
| Aug 3, 2026 | Eric A. Hughes | Sale (10b5-1) | -25,578 | 892K |
| Aug 3, 2026 | Placid Jover | Sale (10b5-1) | -12,827 | 447K |
| Jun 18, 2026 | Matthew Shields | Sale | -9,989 | 322K |
| Jun 11, 2026 | Eliyahu Sharon Kalif | Sale (10b5-1) | -106,563 | 3.6M |
| Jun 5, 2026 | Richard D. Francis | Sale (10b5-1) | -6,153 | 211K |
| Jun 3, 2026 | Matthew Shields | Sale (10b5-1) | -16,195 | 532K |
Show the other 10 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TEVA/export.csv") into a cell.